Catalyst Wire Dossier Catalyst Wire Dossier

AG-920 Topical Ophthalmic Solution

AG-920 topical ophthalmic solution · American Genomics, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AG-920 Topical Ophthalmic Solution, covering 2022-09-28 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution [Phase 3]

See pricing